Genencell Founder Sentenced to 4 Years in Prison and Taken Into Court for Embezzlement in Second Trial Over 'Kim Seung-Won Solicitation Allegations'
5 Articles
5 Articles
The court determined that it was clear that Kang Eumgae, the founder of pharmaceutical company Genencell, asked Kim Seung-won and a member of the Democratic Party to approve the Ministry of Food and Drug Safety (Ministry of Food and Drug Administration) clinical trial plan for COVID-19 treatment. The appellate judge in this case was Kang Yang, a businessman who was a link between the two in exchange for such a solicitation
Kang Se-chan, the founder of Genencell who was implicated in allegations of soliciting favors from former Justice Minister nominee Kim Seung-won, was sentenced to four years in prison and fined 40 million won in the second trial and was taken into custody in court. The court overturned the suspended sentence handed down in the first trial by finding him guilty of delivering money and goods to solicit clinical trial approval from the Ministry of …
(Seoul = Yonhap News) Reporter Lee Bal-geum = Professor Kang, the founder of Genencell, who is implicated in the allegations of 'COVID-19 clinical trial approval lobbying' involving Democratic Party lawmaker Kim Seung-won, is suspected of breach of trust...
Professor Kang Se-chan of Kyung Hee University and founder of Genencell, who was implicated in the ‘COVID-19 clinical trial approval lobbying’ allegations involving Democratic Party lawmaker Kim Seung-won, who was nominated as Minister of Justice, was sentenced to prison in an appeal trial on charges including breach of trust and was taken into custody in court. The appellate court determined that it was evident Professor Kang had solicited appr…
Professor Kang, the founder of Genencell who was implicated in the 'COVID-19 clinical trial approval lobbying' allegations involving Democratic Party lawmaker Kim Seung-won, a former nominee for Minister of Justice, was sentenced to imprisonment in the appellate trial and taken into custody.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
